BCM
PDLI

Barometer Capital Management’s PDL BioPharma, Inc. PDLI Stock Holding History

Barometer Capital Management’s Portfolio PDLI Stock Details PDLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-2,855
Closed -$28K – 174
2014
Q2 		$28K Buy
+2,855
New +$25.4K 0.01% 92

Other funds holding PDLI

ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Barometer Capital Management's PDLI Position: Q3 2014 in Review

Barometer Capital Management sold out of PDL BioPharma, Inc. (PDLI) in Q3 2014, closing a stake of 2,855 shares — an estimated $28K sold.

Barometer Capital Management first reported a position in PDLI in Q2 2014 and held it in 1 quarter. The position peaked at $28K in Q2 2014. 231 funds tracked by Wall St. Rank hold PDLI as of Q3 2014.

  • Barometer Capital Management reported no remaining PDL BioPharma, Inc. position as of Q3 2014 after selling out during the quarter.
  • Barometer Capital Management sold 2,855 PDL BioPharma, Inc. shares in Q3 2014, an estimated $28K.
  • Barometer Capital Management first reported a position in PDL BioPharma, Inc. in Q2 2014 and held it in 1 quarter.
  • Barometer Capital Management's PDL BioPharma, Inc. position peaked at $28K in Q2 2014.
  • 231 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q3 2014.

Based on Barometer Capital Management's 13F filing for Q3 2014, filed 12 Nov 2014.